Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercialization
Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercialization